Tt International Asset Management LTD Gilead Sciences, Inc. Transaction History
Tt International Asset Management LTD
- $697 Million
- Q3 2025
A detailed history of Tt International Asset Management LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tt International Asset Management LTD holds 9,000 shares of GILD stock, worth $1.12 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
9,000
Previous 9,000
-0.0%
Holding current value
$1.12 Million
Previous $997,000
0.2%
% of portfolio
0.14%
Previous 0.26%
Shares
6 transactions
Others Institutions Holding GILD
# of Institutions
2,366Shares Held
1.01BCall Options Held
8.63MPut Options Held
7.39M-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.8 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...